InvestorsHub Logo
icon url

MagnumStocks

04/30/18 11:46 AM

#11615 RE: MagnumStocks #11614

Once again, Kiener is not a newbie to biopharma but a vetted industry professional and builder:

During Dr. Kiener's more than 20 years as pharmaceutical executive, he has played a significant role in moving various programs through all aspects of drug development, including discovery, regulatory approval, and post marketing. He has also been substantially involved in the execution of multiple deal types, including private placements, IPO, M&A, strategic partnerships, and licensing deals. He has published more than 120 papers in peer-reviewed journals and is an inventor on more than 40 patents and patent applications.

icon url

BullsOnFire

04/30/18 12:54 PM

#11630 RE: MagnumStocks #11614

just a matter of time for them I think...I also believe there's a decent opportunity for a penny stock of the year